Celgene Bioengineer I in Warren, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Independently design, perform, and interpret complex experiments to support analytical method characterization and validation. Leads and advances analytical projects from Analytical R&D to Quality Operations.
Responsibilities may include, but are not limited to, the following:
Lead analytical method validation(s), which may include the following types of methods: flow cytometry, ELISA, cell counting, qPCR, microbiological/safety, etc.
Execute/implement analytical experiments of substantial multi-variant complexity.
Author and/or review analytical method validation protocols, reports, and/or regulatory documents.
Assist in the transfer of analytical methods to transfer group and/or Quality Control.
Perform tracking/trending of data to contribute to the life cycle management of an analytical method.
Train end-users and entry level personnel on analytical methods.
Present research findings to other groups. Build relationships with cross-functional teams. Provide broader scientific guidance to other departments.
Anticipate process problems. Raise issues; recommend solutions to department management.
Act as a key resource/contributor in specific area of expertise within the department. Lead achievement of project milestones with significant departmental impact.
Maintain a basic knowledge of cell therapy development and awareness of competitive landscape.
Ensure proper operation and perform routine maintenance of all laboratory equipment.
Maintain a safe workplace in accordance with company and OSHA policies/procedures.
B.S. in Biology or related discipline with 5-8 years of recent, relevant experience or M.S. with 3-6 years of recent, relevant experience.
Proficiency in analytical skills: statistical analysis and effective presentation of analysis to other groups.
Ability to write scientific technical protocols and reports that require minimal revision on content.
Ability to work with minimal technical supervision and perform operational tasks independently.
Able to assess risk and develop contingency plans for process risks.
Highly motivated and have a drive to acquire new skills.
Expertise in mammalian cell culture and diverse analytical techniques preferred.
Experience working in a GMP regulated environment.
Excellent verbal and written communication skills
Please visit www.celgene.com to learn more about current opportunities at Celgene. To apply for this position, please visit the career section.
Celgene Corporation is an equal opportunity employer.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.